Eragny-sur-Oise (France), October 13, 2015 – SAFE ORTHOPAEDICS (Euronext: FR0012452746 – SAFOR), a company developing and marketing an innovative range of sterile implants combined with their single-use surgical instruments, today announces that the U.S. Food and Drug Administration (FDA) has approved